Validated by the Only Randomized Clinical Trial
Tru-D has been validated by more than 20 independent studies, including the only randomized clinical trial on UV disinfection. The Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study found that the addition of Tru-D to standard cleaning strategies has been shown to reduce the relative risk of colonization and infection of four major superbugs by a cumulative 30 percent among patients admitted to the same room when 93 percent compliance of standard disinfection protocols occurred. Individual hospital results may vary. This not only provides better care for patients, but it can also lead to significant cost savings to hospitals.
The Role of the Environment
Over the past decade, researchers have concluded that manual disinfection is inadequate for terminal room disinfection. According to studies, more than 50% of health care surfaces are not properly disinfected, leaving behind pathogens that increase the risk of infection by 39 – 353% for the next patient who enters the room. In fact, according to a study by Jefferson, et al, on average, only 25% of targeted surfaces in 71 operating rooms had been properly cleaned.
In a recent study published in the American Journal of Infection Control, Tru-D was proven to reduce bioburden on anesthesia workstations. In the study, UVC disinfection greatly influenced bioburden reduction regardless of room size and exposure type. All trials, compared with the controls, exhibited a bioburden reduction of more than 99 percent. The research team went on to suggest that Tru-D’s technology is an important supplement to the manual cleaning process.
As important as handwashing, manual cleaning and antibiotic stewardship are to your infection prevention protocols in the OR, so is incorporating enhanced terminal room disinfection. To learn more about Tru-D’s technology in OR Today, click here or for hospital testimonials in Outpatient Surgery Magazine, click here.